Breaking News

Archimica To Supply API for NicOx Drug

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NicOx S.A. has signed an agreement with Archimica for the commercial manufacturing and supply of naproxcinod API. Naproxcinod is NicOx’s lead candidate in the COX-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents. NicOx expects to file a NDA for naproxcinod with the FDA mid-2009.     Michele Garufi, chairman and chief executive officer of NicOx, said, “We are very happy to have signed this agreement with Archimica, which is an essential step as we advance ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters